Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B-Reference-Cited by-同舟云学术

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B

Published:2019-10-15 Issue:2 Volume:27 Page:118-126
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Papatheodoridi Margarita¹,Hadziyannis Emilia²,Berby Françoise³,Zachou Kalliopi⁴,Testoni Barbara³^ORCID,Rigopoulou Eirini⁴,Gatselis Nikolaos K.⁴,Lyberopoulou Aggeliki⁴,Vlachogiannakos Ioannis¹,Manolakopoulos Spilios¹²,Dalekos George N.⁴,Zoulim Fabien³^ORCID,Papatheodoridis George V.¹^ORCID

Affiliation:

1. Department of Gastroenterology Medical School of National and Kapodistrian University of Athens General Hospital of Athens “Laiko” Athens Greece

2. 2nd Department of Internal Medicine Medical School of National and Kapodistrian University of Athens General Hospital of Athens “Hippokratio” Athens Greece

3. INSERM U1052 ‐ Cancer Research Center of Lyon (CRCL) Lyon France

4. Department of Medicine and Research Laboratory of Internal Medicine Thessaly University Medical School Larissa Greece

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13211

Reference23 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection